Global Artificial Blood Competitive Landscape Professional Research Report 2025
Description
Research Summary
Artificial blood is a substance that mimics the oxygen-carrying properties of red blood cells. It is designed to replace or supplement the use of donated blood in transfusions, and can be used in emergency situations where donated blood is unavailable or in limited supply. Artificial blood is typically made using hemoglobin, the protein in red blood cells that carries oxygen, and can be either a standalone product or combined with other materials to form a blood substitute. While artificial blood research and development has been ongoing for several decades, no commercially available product has yet been widely adopted for human use.
According to DIResearch's in-depth investigation and research, the global Artificial Blood market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Artificial Blood include Dextro-Sang Corporation, BioPure Corporation, Sangart, Northfield Laboratories, Baxter International, Dentritech, FluorO2 Therapeutics, Nuvox Pharma, Alpha Therapeutic Corporation, HemoBioTech etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Artificial Blood. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Artificial Blood market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Artificial Blood market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Artificial Blood industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Artificial Blood Include:
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech
Artificial Blood Product Segment Include:
Human Blood
Synthetic Blood
Animal Blood
Artificial Blood Product Application Include:
Hemoglobin-Based Oxygen Carriers (HBOCs)
Perflurocarbon Emulsions (PFCEs)
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Artificial Blood Industry PESTEL Analysis
Chapter 3: Global Artificial Blood Industry Porter’s Five Forces Analysis
Chapter 4: Global Artificial Blood Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Artificial Blood Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Artificial Blood Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Artificial Blood Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Artificial Blood Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Artificial Blood Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Artificial Blood Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Artificial Blood Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Artificial Blood Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Artificial blood is a substance that mimics the oxygen-carrying properties of red blood cells. It is designed to replace or supplement the use of donated blood in transfusions, and can be used in emergency situations where donated blood is unavailable or in limited supply. Artificial blood is typically made using hemoglobin, the protein in red blood cells that carries oxygen, and can be either a standalone product or combined with other materials to form a blood substitute. While artificial blood research and development has been ongoing for several decades, no commercially available product has yet been widely adopted for human use.
According to DIResearch's in-depth investigation and research, the global Artificial Blood market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Artificial Blood include Dextro-Sang Corporation, BioPure Corporation, Sangart, Northfield Laboratories, Baxter International, Dentritech, FluorO2 Therapeutics, Nuvox Pharma, Alpha Therapeutic Corporation, HemoBioTech etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Artificial Blood. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Artificial Blood market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Artificial Blood market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Artificial Blood industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Artificial Blood Include:
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech
Artificial Blood Product Segment Include:
Human Blood
Synthetic Blood
Animal Blood
Artificial Blood Product Application Include:
Hemoglobin-Based Oxygen Carriers (HBOCs)
Perflurocarbon Emulsions (PFCEs)
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Artificial Blood Industry PESTEL Analysis
Chapter 3: Global Artificial Blood Industry Porter’s Five Forces Analysis
Chapter 4: Global Artificial Blood Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Artificial Blood Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Artificial Blood Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Artificial Blood Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Artificial Blood Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Artificial Blood Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Artificial Blood Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Artificial Blood Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Artificial Blood Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Artificial Blood Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Artificial Blood Product by Type
- 1.2.1 Human Blood
- 1.2.2 Synthetic Blood
- 1.2.3 Animal Blood
- 1.3 Artificial Blood Product by Application
- 1.3.1 Hemoglobin-Based Oxygen Carriers (HBOCs)
- 1.3.2 Perflurocarbon Emulsions (PFCEs)
- 1.4 Global Artificial Blood Market Revenue and Sales Analysis
- 1.4.1 Global Artificial Blood Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Artificial Blood Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Artificial Blood Market Sales Price Trend Analysis (2020-2032)
- 1.5 Artificial Blood Industry Trends and Innovation
- 1.5.1 Artificial Blood Industry Trends and Innovation
- 1.5.2 Artificial Blood Market Drivers and Challenges
- 2 Artificial Blood Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Artificial Blood Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Artificial Blood Market Analysis by Regions
- 4.1 Global Artificial Blood Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Artificial Blood Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Artificial Blood Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Artificial Blood Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Artificial Blood Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Artificial Blood Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Artificial Blood Sales and Market Share Forecast by Region (2026-2032)
- 4.4 Global Artificial Blood Sales Price Trend Analysis (2020-2032)
- 5 Global Artificial Blood Market Size by Type and Application
- 5.1 Global Artificial Blood Market Size by Type
- 5.1.1 Global Artificial Blood Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Artificial Blood Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Artificial Blood Market Size by Application
- 5.2.1 Global Artificial Blood Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Artificial Blood Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Artificial Blood Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Artificial Blood Market Size by Type
- 6.3.1 North America Artificial Blood Sales by Type (2020-2032)
- 6.3.2 North America Artificial Blood Revenue by Type (2020-2032)
- 6.4 North America Artificial Blood Market Size by Application
- 6.4.1 North America Artificial Blood Sales by Application (2020-2032)
- 6.4.2 North America Artificial Blood Revenue by Application (2020-2032)
- 6.5 North America Artificial Blood Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Artificial Blood Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Artificial Blood Market Size by Type
- 7.3.1 Europe Artificial Blood Sales by Type (2020-2032)
- 7.3.2 Europe Artificial Blood Revenue by Type (2020-2032)
- 7.4 Europe Artificial Blood Market Size by Application
- 7.4.1 Europe Artificial Blood Sales by Application (2020-2032)
- 7.4.2 Europe Artificial Blood Revenue by Application (2020-2032)
- 7.5 Europe Artificial Blood Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Artificial Blood Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Artificial Blood Market Size by Type
- 8.3.1 China Artificial Blood Sales by Type (2020-2032)
- 8.3.2 China Artificial Blood Revenue by Type (2020-2032)
- 8.4 China Artificial Blood Market Size by Application
- 8.4.1 China Artificial Blood Sales by Application (2020-2032)
- 8.4.2 China Artificial Blood Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Artificial Blood Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Artificial Blood Market Size by Type
- 9.3.1 APAC (excl. China) Artificial Blood Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Artificial Blood Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Artificial Blood Market Size by Application
- 9.4.1 APAC (excl. China) Artificial Blood Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Artificial Blood Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Artificial Blood Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Artificial Blood Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Artificial Blood Market Size by Type
- 10.3.1 Latin America Artificial Blood Sales by Type (2020-2032)
- 10.3.2 Latin America Artificial Blood Revenue by Type (2020-2032)
- 10.4 Latin America Artificial Blood Market Size by Application
- 10.4.1 Latin America Artificial Blood Sales by Application (2020-2032)
- 10.4.2 Latin America Artificial Blood Revenue by Application (2020-2032)
- 10.5 Latin America Artificial Blood Market Size by Country
- 10.6 Latin America Artificial Blood Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Artificial Blood Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Artificial Blood Market Size by Type
- 11.3.1 Middle East & Africa Artificial Blood Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Artificial Blood Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Artificial Blood Market Size by Application
- 11.4.1 Middle East & Africa Artificial Blood Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Artificial Blood Revenue by Application (2020-2032)
- 11.5 Middle East Artificial Blood Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Artificial Blood Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Artificial Blood Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Artificial Blood Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Artificial Blood Average Sales Price by Manufacturers (2021-2025)
- 12.2 Artificial Blood Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Artificial Blood Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Dextro-Sang Corporation
- 13.1.1 Dextro-Sang Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Dextro-Sang Corporation Artificial Blood Product Portfolio
- 13.1.3 Dextro-Sang Corporation Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 BioPure Corporation
- 13.2.1 BioPure Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 BioPure Corporation Artificial Blood Product Portfolio
- 13.2.3 BioPure Corporation Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Sangart
- 13.3.1 Sangart Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Sangart Artificial Blood Product Portfolio
- 13.3.3 Sangart Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Northfield Laboratories
- 13.4.1 Northfield Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Northfield Laboratories Artificial Blood Product Portfolio
- 13.4.3 Northfield Laboratories Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Baxter International
- 13.5.1 Baxter International Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Baxter International Artificial Blood Product Portfolio
- 13.5.3 Baxter International Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 Dentritech
- 13.6.1 Dentritech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Dentritech Artificial Blood Product Portfolio
- 13.6.3 Dentritech Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 FluorO2 Therapeutics
- 13.7.1 FluorO2 Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 FluorO2 Therapeutics Artificial Blood Product Portfolio
- 13.7.3 FluorO2 Therapeutics Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 Nuvox Pharma
- 13.8.1 Nuvox Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Nuvox Pharma Artificial Blood Product Portfolio
- 13.8.3 Nuvox Pharma Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 Alpha Therapeutic Corporation
- 13.9.1 Alpha Therapeutic Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Alpha Therapeutic Corporation Artificial Blood Product Portfolio
- 13.9.3 Alpha Therapeutic Corporation Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.10 HemoBioTech
- 13.10.1 HemoBioTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 HemoBioTech Artificial Blood Product Portfolio
- 13.10.3 HemoBioTech Artificial Blood Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Artificial Blood Industry Chain Analysis
- 14.2 Artificial Blood Industry Raw Material and Suppliers Analysis
- 14.2.1 Artificial Blood Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Artificial Blood Typical Downstream Customers
- 14.4 Artificial Blood Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
